Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000;1999(2):CD001282.
doi: 10.1002/14651858.CD001282.

Beclomethasone for asthma in children: effects on linear growth

P J Sharek  1 , D A Bergman
Affiliations

Beclomethasone for asthma in children: effects on linear growth

P J Sharek et al. Cochrane Database Syst Rev. 2000.

Abstract

Background: Inhaled steroids play a central role in the management of childhood asthma. There is concern about their side effects, especially on growth. However asthma may also cause growth retardation. Growth rates are not stable, so randomised controlled parallel group studies are needed to assess the impact of inhaled steroids on growth. This review is confine to one inhaled steroid, beclomethasone, that is known to have significant levels of systemic absorption.

Objectives: To determine whether inhaled beclomethasone cause significant delay in the linear growth of children with asthma.

Search strategy: The Cochrane Airways Group asthma register was searched. Bibliographies from included studies, and known reviews were searched for additional citations. Personal contact with colleagues and researchers working in the field of asthma were made to identify potentially relevant trials.

Selection criteria: Randomized, controlled trials comparing the effects of beclamethasone to non-steroidal medication (placebo or non-steroidal therapy) on the linear growth of children with asthma.

Data collection and analysis: Data related to the clinical outcome "change in growth" were extracted by two reviewers working independently

Main results: One hundred and fifty-nine citations were identified by the search strategy and bibliography review. Three studies met the inclusion criteria. All used beclomethasone 200 mcg twice daily delivered by dry powder Diskhaler to treat children with mild-moderate asthma. Study duration was 7-12 months. In all three studies, a significant decrease in linear growth occurred in children treated with beclomethasone compared to those receiving placebo or non-steroidal asthma therapy. The average decrease, calculated through meta-analysis, was -1.54 cm per year (95% CI -1.15, -1.94).

Reviewer's conclusions: In children with mild-moderate asthma, beclomethasone 200 mcg twice daily caused a decrease in linear growth of -1.54 cm per year. These studies lasted a maximum of 54 weeks, so it remains unclear whether the decrease in growth is sustained or whether it reverses with 'catch up' after therapy is discontinued. We are unable to comment on growth effects of other inhaled steroids that have potentially less systemic effects. If inhaled steroids are required to control a child's asthma, we recommend using the minimum dose that effectively controls the child's asthma and closely following growth.

PubMed Disclaimer

Conflict of interest statement

Neither of the two authors has any affiliations that might place us in a conflict of interest situation. Neither of the two authors has been involved in an included or excluded trial as Principal Investigator, Steering or Monitoring Committee member, Co‐Investigator or Site Coordinator. Francine Ducharme MD editor, has received some travel support for meeting attendance, research grant and consulting fees from Glaxo‐Dminth Kline Inc.

Figures

1.1
1.1. Analysis
Comparison 1 Inhaled Steroid vs placebo, Outcome 1 Linear growth velocity.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Doull 1995 {published data only}
    1. Doull IJ, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate [see comments]. American Journal of Respiratory and Critical Care Medicine. American Journal of Respiratory and Critical Care Medicine 1995;151(6):1715‐9. - PubMed
Simons 1997 {published data only}
    1. Simons FE, et al. A Comparison of Beclomethasone, Salmeterol, and Placebo in Children with Asthma. New England Journal of Medicine 1997;337:1659‐65. - PubMed
Verberne 1997 {published data only}
    1. Verberne AAPH, Frost C, Jan Roorda R, Laag H, Kerrebijn K, et al. One year Treatment with Salmeterol Compared with Beclomethasone in Children with Asthma. American Journal of Respiratory & Critical Care Medicine 1997;156:688‐95. - PubMed

References to studies excluded from this review

Agertoft 1994 {published data only}
    1. Agertoft L, Pedersen S. Effects of long‐term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respiratory Medicine 1994;88:373‐81. - PubMed
Ahrens 1993 {published data only}
    1. Ahrens J. Risks and safety of asthma therapy [Risiken und Sicherheit der Asthmatherapie]. Therapiewoche 1993;43(50):1950‐1.
Allen 1998 {published data only}
    1. Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman D, Vandewalker ML, et al. Growth in asthmatic children treated with fluticazone propionate. Journal of Pediatrics 1998;132(3 I):472‐7. - PubMed
Apold 1975 {published data only}
    1. Apold J, Djoseland O. Inhaled beclomethasone dipropionate in the treatment of childhood asthma. Postgraduate Medical Journal 1975;51 Suppl 4:104‐5. - PubMed
Arkins 1968 {published data only}
    1. Arkins JA, Schleuter DP, Fink JN. The effect of corticosteroids on methacholine inhalation in symptomatic bronchial asthma. Journal of Allergy 1968;41(4):209‐16. - PubMed
Bennati 1989 {published data only}
    1. Bennati D, Piacentini GL, Peroni DG, Sette L, Testi R, Boner AL. Changes in bronchial reactivity in asthmatic children after treatment with beclomethasone alone or in association with salbutamol. Journal of Asthma 1989;26(6):359‐64. - PubMed
Bisgaard 1990 {published data only}
    1. Bisgaard H, Munck SL, Nielsen JP, Petersen W, Ohlsson SV. Inhaled budesonide for treatment of recurrent wheezing in early childhood. Lancet 1990;336:649‐51. - PubMed
Bisgaard 1993 {published data only}
    1. Bisgaard H. Systemic activity of inhaled topical steroid in toddlers studied by knemometry. Acta Paediatrica 1993;82:1066‐71. - PubMed
Boner 1995 {published data only}
    1. Boner AL, Comis A, Schiassi M, Venge P, Piacentini GL. Bronchial reactivity in asthmatic children at high and low altitude. Effect of budesonide. American Journal of Respiratory and Critical Care Medicine 1995;151(4):1194‐200. - PubMed
Booms 1997 {published data only}
    1. Booms P, Cheung D, Timmers MC, Zwinderman AH, Sterk PJ. Protective effect of inhaled budesonide against unlimited airway narrowing to methacholine in atopic patients with asthma. Journal of Allergy and Clinical Immunology 1997;99(3):330‐7. - PubMed
Clark 1996 {published data only}
    1. Clark DJ, Grove A, Cargill RI, Lipworth BJ. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 1996;51(3):262‐6. - PMC - PubMed
Crowley 1995 {published data only}
    1. Crowley S, Hindmarsh PC, Matthews DR, Brook CGD. Growth and the growth hormone axis in prepubertal children with asthma. Journal of Pediatrics 1995;126(2):297‐303. - PubMed
Crowley 1998 {published data only}
    1. Crowley S, Trivedi P, Risteli L, Risteli J, Hindmarsh PC, Brook CG. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. Journal of Pediatrics 1998;132(3 Pt 1):409‐13. - PubMed
Damsbo 1994 {published data only}
    1. Damsbo N. Budesonide in the treatment of mild asthma. A placebo‐controlled multicenter study in general practice [Budesonid i behandling af mild astma. En placebokontrolleret multicenterundersogelse i almen praksis]. Ugeskrift for Laeger 1994;156(43):6384‐8. - PubMed
De Blic 1996 {published data only}
    1. Blic J, Delacourt C, Bourgeois M, Mahut B, Ostinelli J, Caswell C, et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double‐blind study. Journal of Allergy and Clinical Immunology 1996;98(1):14‐20. - PubMed
Doull 1995(2) {published data only}
    1. Doull IJ, Donovan SJ, Wood PJ, Holgate ST. Bloodspot cortisol in mild asthma: the effect of inhaled corticosteroids. Archives of Disease in Childhood 1995;72(4):321‐4. - PMC - PubMed
Doull 1996 {published data only}
    1. Doull I, Freezer N, Holgate S. Osteocalcin, growth, and inhaled corticosteroids: a prospective study. Archives of Disease in Childhood 1996;74:497‐501. - PMC - PubMed
Doull 1997 {published data only}
    1. Doull lJ, Sandall D, Smith S, Schreiber J, Freezer NJ, Holgate ST. Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5' monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze. Pediatric Pulmonology 1997;23(6):404‐11. - PubMed
Droszcz 1988 {published data only}
    1. Droszcz W, Piotrowska B, Madalinska M, Walajtys‐Rode E, Wieniawska‐Szewczyk E. Clinical results and the adrenal cortex activity in patients with bronchial asthma treated by inhalation of budesonide. Evaluation of the results after 1‐year treatment. Polskie Archiwum Medycyny Wewnetrznej 1988;80(2‐3):70‐5. - PubMed
Du toit 1986 {published data only}
    1. du Toit JI, Salome CM, Woolcock AJ. Short term effects of inhaled corticosteroids on bronchial hyperresponsiveness. Australian‐and‐New‐Zealand‐Journal‐of‐Medicine 1986;16:627.
Eefthimiou 1998 {published data only}
    1. Efthimiou J, Barnes PJ. Effect of inhaled corticosteroids on bones and growth. European Respiratory Journal 1998;11(5):1167‐77. - PubMed
Falliers 1982 {published data only}
    1. Falliers CJ, Petraco AJ. Control of asthma with triamcinolone acetonide aerosol inhalations at 12‐hour intervals. Journal of Asthma 1982;19(4):241‐7. - PubMed
Field 1982 {published data only}
    1. Field HV, Jenkinson PM, Frame MH, Warner JO. Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler. Archives of Disease in Childhood 1982;57(11):864‐6. - PMC - PubMed
Francis 1984 {published data only}
    1. Francis RS, McEnery G. Disodium cromoglycate compared with beclomethasone dipropionate in juvenile asthma. Clinical Allergy 1984;14(6):537‐40. - PubMed
Frank‐Piskorska 1988 {published data only}
    1. Frank‐Piskorska A, Wasek Z, Malinowski R, Lypka A. Long‐term therapy using beclomethasone preparations in our experience. Pneumonologia Polska 1988;56(11):518‐22. - PubMed
Freezer 1995 {published data only}
    1. Freezer NJ, Croasdell H, Doull IJ, Holgate ST. Effect of regular inhaled beclomethasone on exercise and methacholine airway responses in school children with recurrent wheeze. European Respiratory Journal 1995;8(9):1488‐93. - PubMed
Galant 1996 {published data only}
    1. Galant SP, Lawrence M, Meltzer EO, Tomasko M, Baker KA, Kellerman DJ. Fluticasone propionate compared with theophylline for mild‐to‐moderate asthma. Annals of Allergy, Asthma, and Immunology 1996;77(2):112‐8. - PubMed
Ggajanan 1993 {published data only}
    1. Gajanan SG. Inhaled corticosteroids in childhood bronchial asthma. National Medical Journal of India 1993 Mar‐Apr;6(2):76‐7. - PubMed
Haahtela 1991 {published data only}
    1. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Comparison of a beta 2‐agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma [see comments]. New England Journal of Medicine 1991;325(6):388‐92. - PubMed
Henriksen 1985 {published data only}
    1. Henriksen JM. Effect of inhalation of corticosteroids on exercise induced asthma: randomised double blind crossover study of budesonide in asthmatic children. British Medical Journal (Clinical Research Ed.) 1985;291(6490):248‐9. - PMC - PubMed
Hoekstra 1996 {published data only}
    1. Hoekstra MO, Grol MH, Bouman K, Stijnen T, Koeter GH, Kauffman HF, et al. Fluticasone propionate in children with moderate asthma. American Journal of Respiratory and Critical Care Medicine 1996;154(4Pt 1):1039‐44. - PubMed
Horn 1990 {published data only}
    1. Horn CR, Clark TJ, Cochrane GM. Can the morbidity of asthma be reduced by high dose inhaled therapy? A prospective study. Respiratory Medicine 1990;84(1):61‐6. - PubMed
Ishihara 1995 {published data only}
    1. Ishihara K, Hasegawa T, Okazaki M, Katakami N, Sakamoto H, Umeda B, et al. Long‐term follow‐up of patients with a history of near fatal episodes; can inhaled corticosteroids reduce the risk of death from asthma?. Internal Medicine 1995;34(2):77‐80. - PubMed
Jones 1994 {published data only}
    1. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankani JP, Follows RM, et al. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. Respiratory Medicine 1994;88(4):293‐9. - PubMed
Joubert 1985 {published data only}
    1. Joubert JR, Burger G, Shephard E. Inhalation therapy during acute asthma. The role of a combined steroid and beta‐stimulant preparation. South African Medical Journal 1985;68(6):381‐4. - PubMed
Kerstjens 1994 {published data only}
    1. Kerstjens HA, Postma DS, Doormaal JJ, Zanten AK, Brand PL, Dekhuijzen PN, et al. Effects of short‐term and long‐term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group [see comments]. Thorax 1994;49(7):652‐6. - PMC - PubMed
Kerstjens 1995 {published data only}
    1. Kerstjens HA, Schouten JP, Brand PL, Schoonbrood DF, Sterk PJ, Postma DS. Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. The Dutch CNSLD Study Group. American Journal of Respiratory and Critical Care Medicine 1995;151(2Pt 1):360‐8. - PubMed
Kolaczkowska 1996 {published data only}
    1. Kolaczkowska M, Mlynarczyk W, Rzymkowska M. Long‐term corticosteroid therapy as a risk factor of osteoporosis in patients with asthma and chronic bronchitis. Pneumonologia i Alergologia Polska 1996;64(3‐4):196‐203. - PubMed
Kudo 1995 {published data only}
    1. Kudo K, Hojo M, Kabe J. Inhaled beclomethasone in long‐term management of asthma: optimal dose and optimal duration of treatment. Nippon Kyobu Shikkan Gakkai Zasshi (Japanese Journal of Thoracic Diseases) 1995;33(9):956‐65. - PubMed
Laviolette 1994 {published data only}
    1. Laviolette M, Ferland C, Trepanier L, Rocheleau H, Dakhama A, Boulet LP. Effects of inhaled steroids on blood eosinophils in moderate asthma. Annals of the New York Academy of Sciences 1994;725:288‐97. - PubMed
MacKenzie 1998 {published data only}
    1. MacKenzie C. Effects of inhaled corticosteroids on growth. Journal of Allergy & Clinical Immunology 1998;101(4 II):S451‐S455. - PubMed
Maestrelli 1993 {published data only}
    1. Maestrelli P, Marzo N, Saetta M, Boscaro M, Fabbri LM, Mapp CE. Effects of inhaled beclomethasone on airway responsiveness in occupational asthma. Placebo‐controlled study of subjects sensitized to toluene diisocyanate. American Review of Respiratory Disease 1993;148(2):407‐12. - PubMed
Mahajan 1997 {published data only}
    1. Mahajan P, Okamoto LJ, Schaberg A, Kellerman D, Schoenwetter WF. Impact of fluticasone propionate powder on health‐related quality of life in patients with moderate asthma. Journal of Asthma 1997,;34(3):227‐34. - PubMed
Malka 1994 {published data only}
    1. Malka M. Treatment of asthma: research on the minimum effective dose of inhaled corticoids. Results with budesonide. Revue de Medecine Interne 1994;15 Suppl 2:252s‐3s. - PubMed
Malo 1996 {published data only}
    1. Malo JL, Cartier A, Cote J, Milot J, Leblanc C, Paquette L, et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18‐month double‐blind crossover study. American Journal of Respiratory & Critical Care Medicine 1996 Mar;153(3):953‐60. - PubMed
Merkus 1993 {published data only}
    1. Merkus PJ, Essen‐Zandvliet EE, Duiverman EJ, Houwelingen HC, Kerrebijn KF, Quanjer PH. Long‐term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics 1993;91(6):1121‐6. - PubMed
Moller 1996 {published data only}
    1. Moller GM, Overbeek SE, Helden‐Meeuwsen CG, Haarst JM, Prens EP, Mulder PG, et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clinical and Experimental Allergy 1996;26(5):517‐24. - PubMed
Nathan 1997 {published data only}
    1. Nathan RA, Nolop KB, Cuss FM, Lorber RR. A comparison of double‐strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma [see comments]. Chest 1997 Jul;112(1):34‐9. - PubMed
Nyholm 1984 {published data only}
    1. Nyholm E, Frame MH, Cayton RM. Therapeutic advantages of twice‐daily over four‐times daily inhalation budesonide in the treatment of chronic asthma. European Journal of Respiratory Diseases 1984 Jul;65(5):339‐45. - PubMed
Overbeek 1996 {published data only}
    1. Overbeek SE, Kerstjens HA, Bogaard JM, Mulder PG, Postma DS. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups. Chest 1996;110(1):35‐41. - PubMed
Pearlman 1997 {published data only}
    1. Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, et al. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Annals of Allergy, Asthma, and Immunology 1997;78(4):356‐62. - PubMed
Pedersen 1996 {published data only}
    1. Pedersen B, Dahl R, Karlstrom R, Peterson CG, Venge P. Eosinophil and neutrophil activity in asthma in a one‐year trial with inhaled budesonide. The impact of smoking. American Journal of Respiratory and Critical Care Medicine 1996;153(5):1519‐29. - PubMed
Pepys 1975 {published data only}
    1. Pepys J. Effects of inhaled beclomethasone dipropionate on bronchial provocation test reactions. Postgraduate Medical Journal 1975;51 Suppl 4:42‐8. - PubMed
Ponticiello 1997 {published data only}
    1. Ponticiello A, Vatrella A, Parrella R, Romano L, Zofra S, Berlingieri GM, et al. Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics. Monaldi Archives for Chest Disease 1997;52(2):112‐7. - PubMed
Price 1997 {published data only}
    1. Price JF, Russell G, Hindmarsh PC, Weller P, Heaf DP. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatric Pulmonology 1997;24(3):178‐86. - PubMed
Prieto 1994 {published data only}
    1. Prieto L, Berto JM, Gutierrez V, Tornero C. Effect of inhaled budesonide on seasonal changes in sensitivity and maximal response to methacholine in pollen‐sensitive asthmatic subjects. European Respiratory Journal 1994;7(10):1845‐51. - PubMed
Reid 1996 {published data only}
    1. Reid A, Murphy C, Steen HJ, McGovern V, Shields MD. Linear growth of very young asthmatic children treated with high‐dose nebulized budesonide. Acta Paediatrica 1996;85(4):421‐4. - PubMed
Riordan 1974 {published data only}
    1. Riordan JF, Dash CH, Sillett RW, McNicol MW. A comparison of betamethasone valerate, beclomethasone dipropionate and placebo by inhalation for the treatment of chronic asthma. Postgraduate Medical Journal 1974;50(suppl 4):61‐4. - PubMed
Roisman 1995 {published data only}
    1. Roisman GL, Peiffer C, Lacronique JG, Cae A, Dusser DJ. Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. Journal of Clinical Investigation 1995;96(1):12‐21. - PMC - PubMed
Sheffer 1996 {published data only}
    1. Sheffer AL, LaForce C, Chervinsky P, Pearlman D, Schaberg A. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group. Journal of Family Practice 1996;42(4):369‐75. - PubMed
Smith 1987 {published data only}
    1. Smith MJ. The place of high‐dose inhaled corticosteroids in asthma therapy. Drugs 1987;33(5):423‐9. - PubMed
Sparkes 1974 {published data only}
    1. Sparkes CG. Plasma cortisol levels in normal subjects after inhaled corticosteroids. Postgraduate Medical Journal 1974;50:9‐11. - PubMed
Storr 1986 {published data only}
    1. Storr J, Lenney CA, Lenney W. Nebulised beclomethasone dipropionate in preschool asthma. Archives of Disease in Childhood 1986;61(3):270‐3. - PMC - PubMed
Sutochnikova 1996 {published data only}
    1. Sutochnikova OA, Samsonova MV, Cherniak AV, Cherniaev AL, Sokolov AS, Chuchalin AG. The effect of the Russian inhalant glucocorticosteroid budesonide on bronchial inflammation and hyperreactivity during the long‐term treatment of bronchial asthma patients. Terapevticheskii Arkhiv 1996;68(3):48‐50. - PubMed
Taskar 1993 {published data only}
    1. Taskar VS, Mahashur AA, John PJ, Kolhatkar VP, Menon L, Bijur S. Anti‐inflammatory action of steroid inhalers. Journal of the Association of Physicians of India 1993;41(5):281‐3. - PubMed
Taylor 1975 {published data only}
    1. Taylor B, Norman AP. Betamethasone 17‐valerate in childhood asthma. A double‐blind crossover trial in children not taking other corticosteroid therapy. Acta Paediatrica Scandinavica 1975;64(2):234‐40. - PubMed
Tinkelman 1993 {published data only}
    1. Adelroth E, Thompson S. High‐dosage inhalation steroids in asthma‐‐analysis of costs and use in health care. Lakartidningen 1984;81(46):4285‐8. - PubMed
Todd 1997 {published data only}
    1. Todd G, White CM, Milch LR. Fluticasone's effect on growth, pharmacokinetic profile questioned. Hospital Formulary 1997;32(4):319‐24.
Toogood 1987 {published data only}
    1. Toogood JH. Efficiency of inhaled versus oral steroid treatment of chronic asthma. New England & Regional Allergy Proceedings 1987 Mar‐Apr;8(2):98‐103. - PubMed
Toogood 1991 {published data only}
    1. Toogood JH, Jennings B, Hodsman AB, Baskerville J, Fraher LJ. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. Journal of Allergy & Clinical Immunology 1991;88:572‐80. - PubMed
Trigg 1994 {published data only}
    1. Trigg CJ, Manolitsas ND, Wang J, Calderon MA, McAulay A, Jordan SE, et al. Placebo‐controlled immunopathologic study of four months of inhaled corticosteroids in asthma. American Journal of Respiratory and Critical Care Medicine 1994;150(1):17‐22. - PubMed
Van Essen‐Zand 1986 {published data only}
    1. Essen‐Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ. Effects of 22 months of treatment with inhaled corticosteroids and/or beta‐2‐agonists on lung function, airway responsiveness, and symptoms in children with asthma. American Review of Respiratory Disease 1992;146(3):547‐54. - PubMed
Van Essen‐Zand 1992 {published data only}
    1. Essen‐Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ. Effects of 22 months of treatment with inhaled corticosteroids and/or beta‐2‐agonists on lung function, airway responsiveness, and symptoms in children with asthma. American Review of Respiratory Disease 1992;146(3):547‐54. - PubMed
Van Essen‐Zand 1994 {published data only}
    1. Essen‐Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Kerrebijn KF. Remission of childhood asthma after long‐term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. European Respiratory Journal 1994;7(1):63‐8. - PubMed
Van Essen‐Zandv 1995 {published data only}
    1. Essen‐Zandvliet EE. Long‐term intervention in childhood asthma: the Dutch study results. Dutch Chronic Nonspecific Lung Disease Study Group. Monaldi Archives for Chest Disease 1995;50(3):201‐7. - PubMed
Waalkens 1993 {published data only}
    1. Waalkens HJ, Essen‐Zandvliet EE, Gerritsen J, Duiverman EJ, Kerrebijn KF, Knol K. The effect of an inhaled corticosteroid (budesonide) on exercise‐induced asthma in children. Dutch CNSLD Study Group [see comments]. European Respiratory Journal 1993;6(5):652‐6. - PubMed
Wang 1994 {published data only}
    1. Wang JH, Trigg CJ, Devalia JL, Jordan S, Davies RJ. Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma. Journal of Allergy and Clinical Immunology. Journal of Allergy and Clinical Immunology 1994;94(6 Pt 1):1025‐34. - PubMed
Wasserman 1996 {published data only}
    1. Wasserman SI, Gross GN, Schoenwetter WF, Munk ZM, Kral KM, Schaberg A, et al. A 12‐week dose‐ranging study of fluticasone propionate powder in the treatment of asthma. Journal of Asthma 1996;33(4):265‐74. - PubMed
Webb 1986 {published data only}
    1. Webb MS, Milner AD, Hiller EJ, Henry RL. Nebulised beclomethasone dipropionate suspension. Archives of Disease in Childhood 1986;61(11):1108‐10. - PMC - PubMed
Wennergren 1996 {published data only}
    1. Wennergren G, Nordvall SL, Hedlin G, Moller C, Wille S, Asbrink Nilsson E. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers. Acta Paediatrica 1996;85(2):183‐9. - PubMed
Wilken‐Jensen 1975 {published data only}
    1. Wilken‐Jensen K. The effect of inhalations of beclomethasone dipropionate on plasma cortisol levels and growth hormone production. Postgraduate Medical Journal 1975;51(Suppl 4):31‐2. - PubMed
Wilson 1995 {published data only}
    1. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Archives of Disease in Childhood 1995;72:317‐20. - PMC - PubMed
Wolfe 1996 {published data only}
    1. Wolfe JD, Selner JC, Mendelson LM, Hampel F Jr, Schaberg A. Effectiveness of fluticasone propionate in patients with moderate asthma: a dose‐ranging study. Clinical Therapeutics 1996;18(4):635‐46. - PubMed
Wolthers 1995 {published data only}
    1. Wolthers OD, Pedersen S. Measures of systemic activity of inhaled glucocorticosteroids in children: A comparison of urine cortisol excretion and knemometry. Respiratory Medicine 1995;89(5):347‐9. - PubMed
Wyatt 1978 {published data only}
    1. Wyatt R, Waschek J, Weinberger M, Sherman B. Effects of inhaled beclomethasone dipropionate and alternate‐day prednisone on pituitary‐adrenal function in children with chronic asthma. New England Journal of Medicine 1978;299(25):1387‐92. - PubMed
Yazigi 1978 {published data only}
    1. Yazigi R, Sly RM, Frazer M. Effect of triamcinolone acetonide aerosol upon exercise‐induced asthma. Annals of Allergy 1978;40(5):322‐5. - PubMed

Additional references

Ali 1991
    1. Ali NJ. Bone turnover during high dose inhaled corticosteroid treatment.. Thorax 1991;46:160‐4. - PMC - PubMed
Allen 1994
    1. Allen E, Mullen M, Mullen B. A meta‐analysis of the effect of oral and inhaled corticosteroids on growth. Journal of Allergy & Clinical Immunology 1994;93(6):967‐76. - PubMed
Allen 1996
    1. Allen DB. Growth suppression by glucocorticoid therapy. In: Vassallo J, eds editor(s). Endocrinology and metabolism clinics in North America. Philadelphia: W.B. Saunders Co, 1996:699‐717. - PubMed
Balfour‐Lynn 1986
    1. Balfour‐Lynn L. Growth and childhood asthma. Archives of Disease in Childhood 1986;61(11):1049‐55. - PMC - PubMed
Barnes 1993
    1. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. American Review of Respiratory Disease 1993;148:S1‐S26. - PubMed
Begg 1989
    1. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. Journal of the Royal Statistical Society, Series A 1988;151:419‐45.
Beveridge 1996
    1. Beveridge RC, Grunfeld AF, Hodder RV, et al. Guidelines for the emergency management of asthma in adults. CAEP/CTS Asthma Advisory Committee. Canadian Association of Emergency Physicians and the Canadian Thoracic Society. Canadian Medical Association Journal 1996;155(1):25‐37. - PMC - PubMed
Boorsma 1996
    1. Boorsma M, Andersson N, Larsson P, et al. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. European Respiratory Journal 1996;9:1427‐32. - PubMed
British Thor Soc1993
    1. Guidelines on the management of asthma. Statement by the British Thoracic Society, the British Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the British Association of Accident and Emergency Medicine, and the British Paediatric Respiratory Group. Thorax 1993;48(2 Suppl):S1‐S24. - PMC - PubMed
Brown 1993
    1. Brown PH, Matusiewicz SP, Shearing C, et al. Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax 1993;48:967‐73. - PMC - PubMed
Capewell 1990
    1. Capewell S, Reynolds S, Shuttleworth D, et al. Purpura and dermal thinning associated with high dose inhaled corticosteroids. BMJ 1990;300:1548‐51. - PMC - PubMed
Clark 1996
    1. Clark DJ, Grove A, Cargill RI, et al. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 1996;51:262‐6. - PMC - PubMed
Dahl 1993
    1. Dahl R, Lundback E, Malo JL, et al. A dose‐ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993;104:1352‐8. - PubMed
DerSimonian 1986
    1. DerSominan R, Laird N. Meta‐Analysis in clinical trials. Controlled Clinical Trials 1986;7:177‐88. - PubMed
Doull 1998
    1. Doull IJM, Campbell MJ, Holgate ST. Duration of growth suppresive effects of regular inhaled corticosteroids. Archives of Diseases of Childhood 1998;78(2):172‐3. - PMC - PubMed
Doull IJM, Camp2
    1. Doull IJM, Campbell MJ, Holgate ST. Duration of growth suppresive effects of regular inhaled corticosteroids. Archives of Diseases of Childhood 1998;78(2):172‐3. - PMC - PubMed
Fabbri 1993
    1. Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993;48:817‐23. - PMC - PubMed
FDA 1998
    1. Federal Drug Administration, United States Department of Health and Human Services November 9, 1998. FDA requires new pediatric labeling for inhaled, intranasal corticosteroids.. FDA Talk Paper. FDA website, http//www.fda 1988.
Gustafsson 1993
    1. Gustafsson P, Tsanakas J, Gold M, et al. Comparison of the efficacy and safety of inhaled fluticasone 200 mcg/day with inhaled beclomethasone dipropionate 400 mcg/day in mild and moderate asthma. Archives of Disease in Childhood 1993;69:206‐11. - PMC - PubMed
Haahtela 1991
    1. Haahtela T, Jarvinen M, Kava T, et al. Comparison of a beta2‐agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. New England Journal of Medicine 1991;325:388‐92. - PubMed
Hill 1965
    1. Hill, AB. The environment and disease: Association of causation. Proceedings of the Royal Society of Medicine 1965;58:295‐300. - PMC - PubMed
Japan Soc All 1995
    1. Japanese Society of Allergology. Guidelines for the diagnosis and management of bronchial asthma. Committee on the definition, treatment, and management of bronchial asthma. Allergy 1995;50(27):1‐42. - PubMed
Jeffery 1992
    1. Jeffery PK, Godfrey RW, Adelroth E, et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. American Review of Respiratory Disease 1992;145:890‐9. - PubMed
Kamada 1994
    1. Kamada, AK. Therapeutic controversies in the treatment of asthma. Annals of Pharmacotherapy 1994;28(7‐8):904‐14. - PubMed
Kamada 1995
    1. Kamada AK, Szefler SJ. Glucocorticoids and growth in asthmatic children. Pediatric Allergy & Immunology 1995;6:145‐54. - PubMed
Laird 1990
    1. Laird NM, Mosteller F. Some statistical methods for combining experimental results. International Journal of Technology Assessment in Health Care 1990;6(1):5‐30. - PubMed
Last 1995
    1. Last JM (editor). A dictionary of epidemiology. Third Edition. New York, NY: Oxford University Press,, 1995.
Mulrow 1997
    1. Mulrow CD, Oxman AD (eds). Cochrane Collaboration Handbook [updated 1 march 1997]. In: The Cochrane Library [database on disk and CDROM].. In: Mulrow CD, Oxman AD (eds) editor(s). The Cochrane Collaboration.. Oxford: Update Software, 1997:Update Software; 1996‐. Updated quarterly.
Nat Inst Health 1991
    1. National Asthma Education and Prevention Program. National Institutes of Health. Expert Panel Report I: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1991.
Nat Inst Health 1997
    1. National Institutes of Health. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1997:Guidelines for the diagnosis and management of asthma.
Packe 1992
    1. Packe GE, Douglas JG, McDonald AF, et al. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992;47:414‐7. - PMC - PubMed
Pouw 1991
    1. Pouw EM, Prummel MF, Oosting H, Roos CM, Endert E. Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ 1991;302:627‐8. - PMC - PubMed
Prahl 1991
    1. Prahl P. Adrenocortical suppression following treatment with beclomethasone dipropionate and budesonide. Clinical & Experimental Allergy 1991;21:145‐6. - PubMed
Puolijoki 1992
    1. Puolijoki H, Liippo K, Herrala J, et al. Inhaled beclomethasone decreases serum osteocalcin in postmenopausal asthmatic women. Bone 1992;13(4):285‐8. - PubMed
Raffery 1985
    1. Raffery P, Tucker LG, Frame MH, et al. Comparison of budesonide and beclomethasone dipropionate in patients with severe chronic asthma: assessment of relative prednisone‐sparing effects. British Journal of Diseases of the Chest 1985;79:244‐50. - PubMed
Rodrigo, 1998
    1. Rodrigo, C, Rodrigo, G. Salbutamol treatment of acute severe asthma in the ED: MDI versus hand‐held nebulizer. American Journal of Emergency Medicine 1998;16(7):637‐42. - PubMed
Rooklin 1979
    1. Rooklin AR, Lampert SI, Jeager EA, et al. Posterior subcapsular cataracts in steroid‐requiring asthmatic children. Journal of Allergy & Clinical Immunology 1979;63(6):383‐6. - PubMed
S African Pulm 1992
    1. South African Pulmonology Society 1992. Guidelines for the management of asthma in adults in South Africa. Part I. Chronic Persistent Asthma. Working group of the South African Pulmonology Society. South African Medical Journal 1992;81:319‐22. - PubMed
Shaw 1986
    1. Shaw NJ, Edmunds AT Inhaled beclomethasone, oral candidiasis. Inhaled beclomethasone and oral candidiasis. Archives of Disease in Childhood 1986;61:788‐90. - PMC - PubMed
Simons 1993
    1. Simons FE, Persaud MP, Gillspie CA, et al. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet 1993;342:776‐8. - PubMed
Tabachnik 1991
    1. Tabachnik E, Zadik Z. Diurnal cortical secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. Journal of Pediatrics 1991;118:294‐7. - PubMed
Tinkelman 1993
    1. Tinkelman DG, Red CE, Nelson HS, et al. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic mild to moderately severe asthma in children. Pediatrics 1993;92:64‐77. - PubMed
Toogood 1980
    1. Toogood JH, Jennings B, Greenway RW, et al. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. Journal of Allergy & Clinical Immunology 1980;65:145‐53. - PubMed
Toogood 1988
    1. Toogood JH, Crilly RG, Jones G, et al. Effect of high‐dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. American Review of Respiratory Disease 1988;139(1):57‐61. - PubMed
Toogood 1991
    1. Toogood JH, Jennings B, Hodsman AB, et al. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. Journal of Allergy & Clinical Immunology 1991;88:572‐80. - PubMed
Toogood 1993
    1. Toogood JH, Markov AE, Baskerville J, et al. Association of ocular cataracts with inhaled and oral steroid therapy during long‐term treatment of asthma. Journal of Allergy & Clinical Immunology 1993;91:571‐9. - PubMed
Toogood 1995
    1. Toogood JH, Baskerville JC, Markov AE, et al. Bone mineral density and the risk of fracture in patients receiving long term inhaled steroid therapy for asthma. Journal of Allergy & Clinical Immunology 1995;96:157‐66. - PubMed
Turpeinen1991
    1. Turpeinen M, Sorva R, Juntunen‐Backman K. Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. Journal of Allergy & Clinical Immunology 1991;88:384‐9. - PubMed
V Essen‐Zand 1992
    1. Essen‐Zandvliet EE, Hughes MD, Waalkens HJ, et al. Effects of 22 months of treatment with inhaled corticosteroids and /or beta2‐agonists on lung function, airway responsiveness, and symptoms in children with asthma. American Review of Respiratory Disease 1992;146:547‐54. - PubMed
Walker 1988
    1. Walker AM, Mertin‐Morena JM, Artalejo FR. Odd man out: a graphical approach to meta‐analysis. American Journal of Public Health 1988;78(8):961‐6. - PMC - PubMed
Woolcock 1989
    1. Woolcock A, Abraham R, Rubinfeld J, et al. Thoracic Society of Australia and New Zealand. Asthma management plan. Medical Journal of Australia 1989;151:650‐3. - PubMed

Publication types